"Jazz Pharmaceuticals has figured out a way to push the boundaries even further — a feat that demonstrates the lengths to which drug makers go to eke out extra profits and that two federal courts have now ruled was improper."

https://www.nytimes.com/2023/02/28/business/jazz-narcolepsy-avadel-patents.html